CARsgen Therapeutics Company
CARsgen is a leading immunotherapy company focused on the development of new chimeric antigen receptor
Headquarters:
Shanghai,Shanghai,China,Asia
Founded Date:
2014-01-01
Industry:
Advanced BioTech R&D
Employee Number:
501-1000
Sub-Industry:
Gene Therapies (Diseases Treatment)
Investors:
Lilly Asia Ventures, Loyal Valley Capital, Shiyu Capital, Kaitai Capital, KTB Ventures
Ipo Status:
public
City:
Shanghai
Region:
Shanghai
Country:
China
Founders:
Huamao Wang,Zonghai Li